Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Jupiter Wellness, Inc. - Common Stock (NQ: JUPW )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 14, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Jupiter Wellness, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Huge NASDAQ Licensing Agreement: $JUPW Licenses Minoxidil Booster to Taisho: Jupiter Wellness, Inc. (NASDAQ: JUPW)
Via Get News
Topics Intellectual Property
Exposures Intellectual Property
Jupiter Wellness Licenses Minoxidil Booster to Taisho
JUPITER, FL / ACCESSWIRE / June 23, 2022 / Jupiter Wellness (NASDAQ:JUPW) and Taisho Pharmaceutical Co. Ltd (TYO:4581) today announced that Taisho Pharmaceutical has entered into a license agreement... 
From Jupiter Wellness, Inc.
Via AccessWire
$JUPW Acquires the Assets of Applied Biology Inc., a Leading Biotechnology Company Specializing in Hair and Skin Science: Jupiter Wellness, Inc. (NASDAQ: JUPW)
Via Get News
Dr. Andy Goren and Dr. John McCoy Appointed to Senior Scientific Positions at Jupiter Wellness
JUPITER, FL / ACCESSWIRE / June 22, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that Prof. Andy Goren, MD, and John McCoy, PhD have joined Jupiter Wellness as Chief Medical Officer and... 
From Jupiter Wellness, Inc.
Via AccessWire
Exposures COVID-19
Jupiter Wellness Acquires the Assets of Applied Biology Inc., a Leading Biotechnology Company Specializing in Hair and Skin Science
JUPITER, FL / ACCESSWIRE / June 21, 2022 / Jupiter Wellness, Inc. (Nasdaq:JUPW) today announced the acquisition of 100% of the assets of Applied Biology, Inc. a leading biotechnology company... 
From Jupiter Wellness, Inc.
Via AccessWire
Exposures COVID-19
$JUPW Retires 10% of its Outstanding Shares to Increase Shareholder Value: Jupiter Wellness, Inc. (NASDAQ: JUPW)
Via Get News
Jupiter Wellness Announces the Retirement of Approximately 10% of its Outstanding Shares
JUPITER, FL / ACCESSWIRE / June 17, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced the purchase and retirement of 2,433,894 common shares, which reduces the Company's outstanding common... 
From Jupiter Wellness Acquisition Corp
Via AccessWire
Topics Intellectual Property Retirement
Exposures Intellectual Property Pension
Paul Jones Appointed as Senior Project Manager at Jupiter Wellness
JUPITER, FL / ACCESSWIRE / June 2, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that Paul Jones has joined Jupiter Wellness as Senior Project Manager. 
From Jupiter Wellness, Inc.
Via AccessWire
Health & Wellness NASDAQ Brand, 3 Million $ Acquisition, 5 M Dollar Share Buyback Plus: Jupiter Wellness (NASDAQ: JUPW)
Via Get News
Jupiter Wellness, Inc. (NASDAQ: JUPW) to Present JW-300 Topical Burn Treatment at SCALE 2022 Aesthetic Medicine, Plastic Surgery & Medical Dermatology Conference
Via AB Newswire
Jupiter Wellness, Inc. (NASDAQ: JUPW) will present data for Jupiter’s JW-300, a cannabidiol topical treatment for first degree burns, at SCALE 2022 Aesthetic Medicine
Via Get News
Jupiter Wellness' to Present JW-300 Topical Burn Treatment at SCALE 2022 Aesthetic Medicine, Plastic Surgery & Medical Dermatology Conference
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
From Jupiter Wellness, Inc.
Via AccessWire
Jupiter Wellness Inc (NASDAQ: JUPW) Is Set To Offer Clinical Research Services, With the 3 million dollar acquisition of Acquired Ascent Clinical Research
Via AB Newswire
Jupiter Wellness to Offer Clinical Research Services with Acquisition of Ascent Clinical Research: $3 Million Annual Revenue & EBITDA Contribution to Jupiter
IN A BID TO EXPAND JUPITER WELLNESS'S RESEARCH CAPABILITIES AND ENTER THE LUCRATIVE CRO BUSINESS, JUPITER WELLNESS ACQUIRED THE ASSETS OF ASCENT CLINICAL RESEARCH JUPITER, FL / ACCESSWIRE / April 27,... 
From Jupiter Wellness, Inc.
Via AccessWire
Jupiter Wellness Appoints E-Commerce & Marketing Team to Drive Sales of its Growing Portfolio of Proprietary Health and Wellness Brands
JUPITER, FL / ACCESSWIRE / April 18, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that it has appointed three sales and marketing executives to its team to drive sales of its... 
From Jupiter Wellness, Inc.
Via AccessWire
Jupiter Wellness to Launch CaniSun for Shark Defense Sunscreen with Patented Shark Repellents
Exclusive Worldwide Rights to Patented Shark Repellent Technologies for the Sun and Skin Market Licensed From Shark Defense Technologies, the Leader in Its Field Featured in Numerous Media Outlets... 
From Jupiter Wellness, Inc.
Via AccessWire
Article "Novel Cannabidiol Aspartame Combination Treatment (JW-100) Significantly Reduces ISGA Score in Atopic Dermatitis: Results From a Randomized Double-Blinded Placebo-Controlled Interventional Study" Published in Journal of Cosmetic Dermatology
Authored by an International Group of Leading Dermatology Researchers and Clinicians Who Conducted the Studies JUPITER, FL / ACCESSWIRE / April 6, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today... 
From Jupiter Wellness, Inc.
Via AccessWire
Jupiter Wellness Launches NoStingz Jellyfish Protective Sunscreen Backed by Patent-Pending Formula in $13 B Sunscreen Market
- Jupiter licenses exclusive worldwide rights for unique formulas addressing jellyfish and man o' war stings, sea lice, and swimmer's itch with 4 patents-pending - Estimated 150 million people are... 
From Jupiter Wellness, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Jupiter Wellness Completes Enrollment in Double-Blind Placebo-Controlled Clinical Trial of JW-200 for the Treatment of Actinic Keratosis
Data expected Q1 2022 on efficacy of JW-200 to clear AK lesions, a common form of pre-cancerous growth that left untreated can lead to cancer in up to 15% of patients JUPITER, FL / ACCESSWIRE /... 
From Jupiter Wellness, Inc.
Via AccessWire
Jupiter Wellness Merger Partner Next Frontier's Executive Chairman Shannon Soqui Interview with Benzinga
JUPITER, FL / ACCESSWIRE / February 15, 2022 / Jupiter Wellness, Inc. (Nasdaq:JUPW) today announced that its merger partner Next Frontier Pharmaceuticals' Executive Chairman Shannon Soqui was... 
From Jupiter Wellness, Inc.
Via AccessWire
Jupiter Wellness’ CEO Brian John & Next Frontier’s Executive Chairman Shannon Soqui Interviewed on SNN Network
Corporate Presentation Highlights Merged Company's Strength as Leading Drug Developer Focused on Pharma Cannabinoids: LINK JUPITER, FL / ACCESSWIRE / February 2, 2022 / Jupiter Wellness, Inc.... 
From Jupiter Wellness, Inc.
Via AccessWire
Jupiter Wellness' Merger Partner Next Frontier Pharmaceuticals, Inc. Announces Plans for Oral Dronabinol Solution for the Treatment of Alzheimer's Disease Agitation
- Next Frontier Pharmaceuticals is pursuing FDA 505(b)(2) fast-track approval with its previously FDA approved oral dronabinol (THC) solution - Next Frontier Pharmaceuticals has completed a pre-IND... 
From Jupiter Wellness, Inc.
Via AccessWire
Exposures Product Safety
Jupiter Wellness Announces Board Approval of $5.0 Million Share Buyback Program
Represents Approximately 30% of Jupiter Wellness's Outstanding Shares at current market price JUPITER, FL / ACCESSWIRE / January 25, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it its... 
From Jupiter Wellness, Inc.
Via AccessWire
Jupiter Wellness to Dividend SRM Entertainment Subsidiary to its Stockholders
SRM Entertainment to raise up to $10 million and seek listing on Nasdaq Creates a "Pure Play" Drug Developer in Jupiter Wellness upon the Completion of its Pending Merger with Next Frontier... 
From Jupiter Wellness, Inc.
Via AccessWire
Jupiter Wellness' Merger Partner Next Frontier Pharmaceuticals, Inc. Enters Psychedelic Drug Development and API Market
Next Frontier Pharmaceuticals' Subsidiary Benuvia Signs Agreement with Global Wellness' Shanti Therapeutics - Benuvia has begun focusing on Psilocybin, DMT, and MDMA. - Benuvia's 83,000 square foot... 
From Jupiter Wellness, Inc.
Via AccessWire
Exposures Product Safety
Jupiter Wellness Issues Letter to Stockholders
JUPITER, FL / ACCESSWIRE / January 10, 2022 / Jupiter Wellness Issues Letter to Stockholders: Dear Fellow Stockholders, Jupiter Wellness, Inc. ("Jupiter", or the "Company"), has, we believe,... 
From Jupiter Wellness, Inc.
Via AccessWire
Jupiter (JUPW) Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Jupiter Wellness, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – JUPW
From Halper Sadeh LLP
Via Business Wire
The NEXT Big Merger is Underway on the NASDAQ: JUPW Signs Definitive Agreement to Merge with Next Frontier Pharmaceuticals
Via Get News
Exposures Product Safety
Jupiter Wellness Signs Definitive Agreement to Merge with Next Frontier Pharmaceuticals, a Leading Drug Developer and Manufacturer of Synthetic Cannabinoid Pharmaceuticals
- Owner of SYNDROS®(dronabinol), the only US-based FDA approved CII Tetrahydrocannabinol (THC), a liquid cannabinoid used in adults to treat: Chemotherapy Induced Nausea and Vomiting (CINV) associated... 
From Jupiter Wellness, Inc.
Via AccessWire
Topics Cannabis Intellectual Property Regulatory Compliance
Exposures Cannabis Intellectual Property Legal
TLRY is Making waves with this NASDAQ; JW-300 Demonstrates Efficacy in Treatment of Developing Burns (sunburn) in a Double-Blinded Placebo Controlled Clinical Trial (NASDAQ: JUPW) Jupiter Wellness
Via Get News
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.